Affiliation:
1. Tehran Medical Sciences, Islamic Azad University
2. Imam Khomeini Hospital
Abstract
Abstract
Background
Myeloid or lymphoid progenitors in the bone marrow can develop into leukemia, which is clonal cancer. Acute myeloid leukemia (AML) developed as a result of somatic mutations in the precursor cells of the myeloid lineage along with transcriptome dysregulation of bone marrow infiltration, which resulted in the generation of immature myeloid cells (blasts) and disruption of normal hematopoiesis. Current research has demonstrated the metastasis potential of a certain subset of microRNAs. As a result, miRNA downregulation at the transcriptional level can reduce the possibility of metastasis. The purpose of this work is to analyze miRNA precursor targeting utilizing the CRISPR-C2c2 (Cas13a) method.
Results
crRNAs designed for miR-301b and miR-21 has a very high structural similarity with binding energy to the state observed in the normal condition.
Conclusion
Sequence-based evaluation of crRNAs intended for RNA-level editing is insufficient; simulation and molecular docking investigations should also be carried out for improved accuracy.
Publisher
Research Square Platform LLC
Reference31 articles.
1. Acute myeloid leukaemia;Short NJ;The Lancet,2018
2. Acute Myeloid Leukemia;Dohner H;N Engl J Med,2015
3. Gholamzad A, Daryoushi G, Khatibi M, Khonche S, Ahmadpour A, Malek M, Mehrkhah A, Re-zazadeh H, Sichani AB, Jafari P. A Comprehensive Review in Novel Therapeutics in Acute Leukemia. IJCMCR 2022; 19 (5), 3:46–46.
4. The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients;Klastersky J;J Clin Oncol,2000
5. Role of MicroRNA-30c in cancer progression;Han W;J Cancer,2020